Identification of potential characteristic genes in sepsis utilizing RNA sequencing and gene silence Authors: Hongying Cao, Nianying Qin, Yiling Zhai, Chunyang Dong, Zhou Huang, Dongling Huang, Jincheng Li, Jie Yang, Fan Wang, Wanxia Wei, Wei Wang Published: 2025 ABSTRACT AbstractBackgroundSepsis represents a serious condition involving organ dysfunction that can be life-threatening, posing a significant threat to human health. The mortality rate associated with sepsis ranges from 10% to 40%, with severe cases or those involving septic shock exhibiting mortality rates exceeding 50%.ObjectiveGene sequencing took place on the blood samples that were collected both healthy volunteers and septic patients in this study. Advanced methodologies, including bioinformatics analysis, quantitative PCR (qPCR), meta-analysis, and single-cell localization analysis, were employed to identify potential biomarkers associated with the immunomodulation of sepsis. The identified molecular markers were further validated through the establishment of a sepsis cell model, gene silence techniques, and an ELISA test experiments to assess inflammatory factors.MethodsIn this study, 23 individuals with sepsis and 10 healthy volunteers as controls, and peripheral blood samples were collected. The blood specimens were processed with the assistance of BGI for comprehensive gene sequencing. Post-sequencing, the data underwent quality control measures and were subsequently analyzed using the online platform iDEP 2.01 (http://bioinformatics.sdstate.edu/idep/) to identify differentially expressed genes. Conduct Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses on the identified differentially expressed genes.To elucidate core genes from multiple perspectives, a PPI network was created with the help of the STRING database (https://cn.string-db.org/),facilitating the examination of gene interactions in terms of protein. Following the recognition of core genes, sepsis-associated data sets were obtained from the Gene Expression Omnibus (GEO) public database. Specifically, the transcriptional expression of the gene S100A11 was analyzed using meta-analysis techniques, and its survival curve was subsequently evaluated.The S100A11 gene, identified through screening, was analyzed using an online visualization system to determine its single-cell localization. Initial findings indicated that the gene is predominantly expressed in macrophages. (THP-1 cells) are known as a human monocytic cell line utilized in studies.We cultured THP-1 cells and differentiated into macrophages, followed by stimulation and transfection with the S100A11 gene. The interference effect of S100A11 was assessed using quantitative fluorescence PCR (qPCR). Subsequently, THP-1 cells were cultured to establish a septic cell model, and S100A11 gene silence experiments were conducted, categorizing the samples into control, sepsis, and gene silence sepsis groups. ELISA was employed to assess the concentrations of the inflammatory cytokine IL-1β, TNF-α, and IL-6.ResultsResults demonstrated that S100A11 is highly expressed in sepsis and is primarily localized in macrophages. The enrichment in signaling pathways, including Th1 and Th2 cell differentiation, Th17 cell differentiation, Staphylococcus aureus infection, and cytokine-cytokine receptor interaction, was uncovered by differential gene expression analysis.S100A11 serves as a critical regulatory node for the inflammatory cytokines IL-1β, TNF-α, and IL-6.ConclusionNotably, S100A11 was found to be highly expressed in patients with sepsis. This gene plays a crucial role in promoting inflammation during the septic inflammatory response and may be involved in macrophage differentiation, immunomodulation, and the inflammatory processes associated with sepsis.Keywords: Sepsis, S100A11, RNA sequencing, Gene silence sepsis groups techniques, Inflammatory response Background Sepsis occurs due to an unregulated immune reaction to an infection [1]. Characterized by multiple organ dysfunction syndrome (MODS), sepsis endangers human life and well-being.It represents a severe syndrome induced by the body’s impaired function across multiple organs. The clinical progression of sepsis involves an initial SIRS, leading to a subsequent phase characterized by immunosuppression known as the compensatory anti-inflammatory response syndrome (CARS) [2, 3]. Early detection of sepsis and severe sepsis is crucial, as it can significantly reduce mortality risk, underscoring the importance of identifying potential biomarkers [4–6]. Prompt recognition and appropriate intervention within the initial hours of sepsis onset can substantially enhance patient outcomes. Many studies have shown a link between sepsis and specific genetic markers. Recent research has highlighted significant variations in the expression of sepsis-related biomarker genes among patients with acute infection, sepsis, and septic shock, suggesting their utility as indicators for sepsis screening [7]. Furthermore, genetic testing has been shown to possess superior sensitivity and specificity as a sepsis biomarker compared to procalcitonin (PCT). The start and evolution of sepsis are likely intricately related to immune dysfunction. Throughout the early and later stages of sepsis, T cells are pivotal in either suppressing immune function or contributing to immune hyperactivity [8]. Immunomodulation is thus a important factor in the pathogenesis and the advancement of sepsis. The S100 protein family, characterized by calcium-binding properties, plays an important part in immune responses and inflammation. These proteins are integral to the body’s inflammatory response [9]. Under pathological conditions, a variety of immune cells, such as lymphocytes, macrophages, and neutrophils, enhance the expression of S100 proteins in the extracellular milieu, releasing them in large vesicles derived from the plasma membrane in response to inflammation and cellular stress [10]. These proteins engage with a range of cell surface receptors, activating multiple inflammatory signaling pathways, and consequently promoting the expression of inflammatory agents like TNF-α, IL-1β, IL-6, and IL-8.Additionally, Th17 cells contribute to autoimmune and inflammatory responses by secreting proinflammatory cytokines.A wide variety of cell types, such as T cells and natural killer (NK) cells, express the IL-27 receptor [11]. IL-27 triggers the JAK/STAT signaling pathway when it binds to its receptor, eliciting a specific immunomodulatory response [12]. Empirical evidence indicates that IL-27 can enhance the early immune response to infectious stimuli, thereby facilitating a robust immune reaction [13]. Initial investigations into the function of IL-27 suggest that it is instrumental in promoting the early activation of immature CD4 + T cells and their differentiation into the Th1 lineage [11, 14]. Materials and methods Sample collection and preservation This research project received approval from the Ethics Committee of the Affiliated Hospital of Southwest Medical University, with the ethics approval number ky2018029. All individuals involved, whether sepsis patients, healthy volunteers, or their legal representatives, gave their informed consent in writing. The research included 23 sepsis patients who were admitted to the Emergency Intensive Care Unit at the Affiliated Hospital of Southwest Medical University between January 2019 and December 2019 (n = 23), along with 10 healthy volunteers (n = 10). In the cohort of enrolled sepsis patients, pulmonary infections were observed in 9 cases, abdominal infections in 5 cases, biliary tract infections in 3 cases, skin infection in 1 case, parapharyngeal space infection in 1 case, perianal infection in 1 case, urinary tract infection in 1 case, and infections with unspecified sites in 2 cases.Participants were included if they met the following criteria: (1) a confirmed sepsis diagnosis and admission to the EICU; (2)compliance with the Sepsis 3.0 diagnostic criteria for sepsis (infection + SOFA score ≥ 2) published by the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Medicine (ESICM) in 2016; and (3) an age range of 16 to 65 years; (4) Obtaining informed consent from the participant or their legal representative to enroll in the study and sign the informed consent document. Exclusion criteria include: (1) previous organ failure, (2) with a history of autoimmune diseases or those who are immunocompromised, (3) previous hematologic disorders, and (4) unwillingness to join the study.This study adheres to all guidelines and principles outlined in the Declaration of Helsinki. Peripheral blood samples from both healthy volunteers and sepsis patients were gathered and kept at −80 °C in the Biospecimen Library of the Affiliated Hospital of Southwest Medical University for RNA sequencing analysis later on. RNA sequencing Concurrently, blood test samples from every single one septic patient and healthy volunteer were submitted for genetic sequencing.The mRNA sequence analysis was carried out supported by of BGI (Shenzhen, China). To summarize, blood cells from the peripheral circulation had their total RNA extracted using TRIzol (Invitrogen, Carlsbad, CA, USA).The Agilent 2100 Bioanalyzer (Agilent, Santa Clara, USA) was employed to assess and quantify RNA integrity numbers (RINs). To ensure quality, mRNA needed to have a 28 S/18S ratio exceeding 1, whereas miRNA needed a ratio greater than 1.5.Following the removal of ribosomal RNA (rRNA) using SPRI beads for reversible immobilization from the complete RNA.The RNA fragments were fragmented into smaller pieces in accordance with the kit manufacturer’s protocol. Following this, the fragmented RNA underwent reverse transcription to form complementary DNA (cDNA).Then the cDNA was amplified through polymerase chain reaction (PCR) to establish a cDNA library.The library’s quality control and quantification were performed with an Agilent 2100 Bioanalyzer and real-time qPCR utilizing a TaqMan Probe.The DNBSEQ platform (BGI-Shenzhen, China) was used for mRNA sequencing of libraries that met the quality requirements.Each sample had 1 µg of total RNA prepared for miRNA library construction after undergoing assessment of quality and measurement.Total RNA was extracted and purified through electrophoresis, aiming at small sections of RNA that correspond to the 18–30 nucleotide bands in the labeled lane, as marked by the 14–30 ssRNA ladder labeling (TAKARA).Following annealing, the small RNAs bound to the linker were converted, complementary DNA (cDNA) was created using SuperScript II reverse transcriptase from Invitrogen, Carlsbad, CA, USA.The cDNA product was then subjected to several rounds.The resultant PCR product was screened for binding to a target fragment of 110–130 base pairs through agarose gel electrophoresis and subsequently purified using the QIAquick gel extraction kit (Qiagen, Valencia, CA). MiRNA libraries were characterized using an Agilent 2100 bioanalyzer and quantified via quantitative PCR (qPCR) employing a TaqMan Probe. The final ligated PCR product underwent miRNA sequencing on the BGISEQ-500 platform (BGI-Shenzhen, China). To process sample reads, Trimmomatic software was employed to eliminate reads, linkers, and low-quality bases, especially when the unknown base (N) content was above 5%.Employing the software tools HISAT and Bowtie2, the processed reads were aligned to the reference genome. Screen differential genes The data underwent sequencing and quality control before being processed with the web-based tool iDEP 2.01 (http://bioinformatics.sdstate.edu/idep/) [10], which standardized data quality using a log2 (CPM + 4) transformation [11]. Differential gene expression analysis was conducted using DESeq2, applying criteria of log2 fold change (log2FC) ≥ 1.5 and a q-value ≤ 0.05 [12], to detect genes that are expressed differently between the blood samples of patients with sepsis and those of healthy volunteers. GO and KEGG functional enrichment analysis Gene Ontology (GO) analysis, a standard strategy for batch gene analysis of datasets, was employed to categorize genes classified under Biological Process (BP), Cellular Component (CC), and Molecular Function (MF) categories, facilitating subsequent classification and screening of gene batches [15]. Additionally, the Kyoto Encyclopedia of Genes and Genomes (KEGG) database was adopted to systematically analyze gene signaling pathways and integrate genomic and functional information. The DEGs identified in this study were further analyzed for GO functions and KEGG pathways, with visualization of the results achieved using R language-based online tools (www.oebiotech.com). Protein-Protein interaction analysis (PPI analysis) We constructed a protein-protein interaction (PPI) network to identify core genes from multiple perspectives by the STRING database (https://cn.string-db.org/) [16].Thereby, we elucidated the interactions between genes at the protein level. PPI network analysis allows researchers to identify potential key targets. In this research, we identified the genes with differential expression (DEGs) using the STRING database. In this study, the lowest value of the connection strength parameter between two proteins was 0.4.The study focuses on biological functions to explain how target genes interact functionally with other genes. Core gene meta-analysis We continue to examine the transcription of various genes across different groups, 10 human peripheral blood sepsis samples were downloaded (GSE163151, GSE232753, GSE95233, GSE69063, GSE243217, GSE236713, GSE185263, GSE154918, GSE134347, GSE100159, (including 15 research papers 15 [17–32]).The reviewed literature was obtained from the publicly accessible GEO database (https://www.ncbi.nlm.nih.gov/geo/). The dataset was adjusted to a normalized state using a log2 transformation and categorized into a sepsis group and a normal control group. A meta-analysis was conducted using the R package MultiMeta, which was employed to confirm the dependability of the trends in how target genes are expressed by examining single genes within the same group across different datasets. Core gene (S100A11) survival curve Utilizing data from GSE65682, which includes 28-day prognostic information for over 400 sepsis patients, we investigated the associations between potential core genes and sepsis outcomes. Location of hub genes in cell clusters We analyzed gene expression patterns in mononuclear cells from both healthy individuals and sepsis patients, identifying three transcriptionally distinct cell clusters. The markers CD14 and CD3E were indicative of monocytes and NK-T cells, respectively, while CD86 was specific to macrophages. We compared the expression of S100A11 and CD86 in immune cells. qPCR analysis of the impact resulting from the silencing of the S100A11 gene In the experimental setup, THP-1 cells were grown in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 37 °C and 5% CO2, and saturated humidity in a sterile incubator. Introduce 3.0 × 10^5 THP-1 cells into a 6-well plate and administer phorbol 12-myristate 13-acetate (PMA) at a final concentration of 50 ng/mL for a duration of 24 h to induce the differentiation of THP-1 cells into macrophages (Mø). Replace the existing culture medium with 1.5 mL of fresh serum-free growth medium. Introduce 125 µL of cell growth medium devoid of antibiotics and serum, or alternatively, OptiMEM® Medium. Incorporate 100 pmol of the target gene S100A11 siRNA, ensuring thorough mixing by gentle pipetting. Subsequently, add 4 µL of Lipo8000™ transfection reagent, again mixing gently by pipetting, and allow the mixture to incubate at room temperature for 20 min. Transfer the prepared mixture to a 6-well plate containing cells, ensuring even distribution by gentle shaking. After an incubation period of 5–6 h, replace the solution. Following a 24-hour transfection period, introduce 100 ng/mL LPS to stimulate the cells for either 6–24 h, as required for downstream experimental analysis.The cells were categorized into three groups: a control group, a sepsis group, and a gene silencing plus sepsis group. In the gene silencing plus sepsis group, the target gene (S100A11) was silenced using siRNA, followed by the addition of Lipo8000™ Transfection Reagent. This mixture was incubated at room temperature for 20 min. After a 24-hour transfection period, 100 ng/mL of LPS was administered to stimulate the cells for either 6–24 h, after which downstream experiments were conducted. In the experimental setup, THP-1 cells were grown in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 37 °C and 5% CO2, and saturated humidity in a sterile incubator. Introduce 3.0 × 10^5 THP-1 cells into a 6-well plate and administer phorbol 12-myristate 13-acetate (PMA) at a final concentration of 50 ng/mL for a duration of 24 h to induce the differentiation of THP-1 cells into macrophages (Mø). Replace the existing culture medium with 1.5 mL of fresh serum-free growth medium. Introduce 125 µL of cell growth medium devoid of antibiotics and serum, or alternatively, OptiMEM® Medium. Incorporate 100 pmol of the target gene S100A11 siRNA, ensuring thorough mixing by gentle pipetting. Subsequently, add 4 µL of Lipo8000™ transfection reagent, again mixing gently by pipetting, and allow the mixture to incubate at room temperature for 20 min. Transfer the prepared mixture to a 6-well plate containing cells, ensuring even distribution by gentle shaking. After an incubation period of 5–6 h, replace the solution. Following a 24-hour transfection period, introduce 100 ng/mL LPS to stimulate the cells for either 6–24 h, as required for downstream experimental analysis.The cells were categorized into three groups: a control group, a sepsis group, and a gene silencing plus sepsis group. In the gene silencing plus sepsis group, the target gene (S100A11) was silenced using siRNA, followed by the addition of Lipo8000™ Transfection Reagent. This mixture was incubated at room temperature for 20 min. After a 24-hour transfection period, 100 ng/mL of LPS was administered to stimulate the cells for either 6–24 h, after which downstream experiments were conducted. Following the manufacturer’s guidelines, RNA was extracted and isolated from the harvested cells of each experimental group using the RNAiso Plus reagent.A spectrophotometer, specifically the Nanodrop 2000 model from Thermo, USA, was employed to quantify RNA concentration. Following this, complementary DNA (cDNA) was created via reverse transcription using the PrimeScript™ RT reagent Kit with gDNA Eraser (Perfect Real Time) from TaKaRa.The conditions for reverse transcription included 15 minutes at 37 °C, followed by 5 seconds at 85 °C, with samples quickly transferred to ice upon finishing.The PerfectStart® Green qPCR SuperMix kit was used for quantitative PCR (qPCR) following the manufacturer’s guidelines on the qTOWER 3G Real-Time PCR System from Analytik Jena AG, Germany.GAPDH was used as the reference gene internally. The cycle threshold (Ct) values were computed, and the levels of relative expression were evaluated using the 2^[-ΔΔCt] method.The primers used for S100A11 were as follows: forward primer (S100A11-F) 5’-CGCCAAACGCACGAGTATT-3’ and reverse primer (S100A11-R) 5’-ATGACAGAAAGGCTGGAAGGAA-3’, yielding a product size of 197 base pairs. Following the manufacturer’s guidelines, RNA was extracted and isolated from the harvested cells of each experimental group using the RNAiso Plus reagent.A spectrophotometer, specifically the Nanodrop 2000 model from Thermo, USA, was employed to quantify RNA concentration. Following this, complementary DNA (cDNA) was created via reverse transcription using the PrimeScript™ RT reagent Kit with gDNA Eraser (Perfect Real Time) from TaKaRa.The conditions for reverse transcription included 15 minutes at 37 °C, followed by 5 seconds at 85 °C, with samples quickly transferred to ice upon finishing.The PerfectStart® Green qPCR SuperMix kit was used for quantitative PCR (qPCR) following the manufacturer’s guidelines on the qTOWER 3G Real-Time PCR System from Analytik Jena AG, Germany.GAPDH was used as the reference gene internally. The cycle threshold (Ct) values were computed, and the levels of relative expression were evaluated using the 2^[-ΔΔCt] method.The primers used for S100A11 were as follows: forward primer (S100A11-F) 5’-CGCCAAACGCACGAGTATT-3’ and reverse primer (S100A11-R) 5’-ATGACAGAAAGGCTGGAAGGAA-3’, yielding a product size of 197 base pairs. The interference effects of eight genes were confirmed using qPCR. The interference effects of eight genes were confirmed using qPCR. ELISA was employed to quantify TNF-α, IL-β, and IL-6 concentrations in the cell supernatant, strictly following the ELISA kit’s manufacturer’s guidelines.Additionally, flow cytometry was conducted to assess the expression of macrophage-specific cell surface antigens CD86 and CD206. ELISA was employed to quantify TNF-α, IL-β, and IL-6 concentrations in the cell supernatant, strictly following the ELISA kit’s manufacturer’s guidelines.Additionally, flow cytometry was conducted to assess the expression of macrophage-specific cell surface antigens CD86 and CD206. Results Sample collection and preservation For this study, blood samples were obtained from sepsis patients(n = 23) and healthy adults(n = 10), and subsequently stored at −80 °C in a biosample library.High-throughput RNA sequencing was conducted on these blood samples. Quality control of gene sequencing results The gene expression dataset was subjected to a log transformation and analyzed via the online software IDEP 2.01 (http://bioinformatics.sdstate.edu/idep/). Quality control examinations indicated that the data were of high quality and comparable, as shown in box plots (Fig. 1A) and principal component analysis (PCA) charts (Fig. 1B), A is a box plot illustrating the quality control of gene expression; B is principal component analysis (PCA) charts, indicated that the data were of high quality and comparable Screen differential genes Following logarithmic preprocessing, further analysis was performed using IDEP 2.01 with thresholds set at |Log2FC| >1.5 and p < 0.01. The study discovered 2151 genes with differential expression between the sepsis and normal groups, with 1145 genes upregulated and 774 genes downregulated.There was a uniform distribution of the DEGs, as shown in the bar chart (Fig. 2A) and volcano plot (Fig. 2B). A is a box plot illustrating the quality control ofis differentially expressed genes (DEGs) bar chart and B is volcano plot, included 2,151 DEGs between the normal and sepsis groups, with 1,145 genes upregulated and 774 genes downregulated GO and KEGG functional enrichment analysis Pathway analysis was conducted on the 2,151 DEGs using the GO functions and KEGG databases. The results of these analyses were visualized utilizing the Oebiotech online tool, which is based on the R programming language. The study showed that these DEGs mainly participate in biological processes like signal transduction and are associated with the extracellular region and space (Fig. 3).Moreover, they play a role in signaling pathways associated with the differentiation of Th1 and Th2 cells, Th17 cell differentiation, Staphylococcus aureus infection, and interactions between cytokines and their receptors (Fig. 4). DEGs involved in biological processes(GO analysis) such as signal transduction, as well as the extracellular region and space Included point graphs(4A), tree graphs(4B), and mesh graphs(4C).DEGs (KEGG functional enrichment analysis) related to Th1,Th2 and Th17 cell differentiation, staphylococcus aureus infection, and cytokine-cytokine receptor interactions Analysis of interactions between proteins (PPI Analysis) A PPI network is created based on earlier research, connecting proteins that have interaction relationships. A target protein with a higher number of connections compared to others is positioned at the core of the network. We analyzed the entire set of 2151 differentially expressed genes (DEGs) to construct a PPI network (Fig. 5) and identified the network of mutual interactions involving approximately 10 genes, including S100A11, S100A8, S100A9, and S100A12. These genes are implicated in several biological processes and molecular functions, such as calcium-dependent protein binding.S100 protein, through calcium-dependent phospholipid binding, phospholipase inhibitor activity, and cadherin binding involved in cell-cell adhesion. Furthermore, they take part in biological functions including the enhancement of plasma membrane repair, reduction of phospholipase A2 activity, stimulation of vesicle fusion, and activation of plasminogen, and membrane raft assembly. S100A11, S100A6, S100A8, S100A9, and S100A12 situated centrally within the protein-protein interaction (PPI) network Gene expression meta-analysis We further examined and curated sepsis datasets, including GSE163151, GSE232753, GSE95233, GSE69063, GSE243217, GSE236713, GSE185263, GSE154918, GSE134347, and GSE100159, from the Gene Expression Omnibus (GEO) public database. The datasets were categorized into sepsis and control groups, and a meta-analysis was conducted to assess the transcription level of the S100A11 gene. The findings indicated that the sepsis group had much higher expression levels than the control group (P < 0.01, Fig. 6). Examined and curated sepsis datasets including GSE163151, GSE232753, GSE95233, GSE69063, GSE243217, GSE236713, GSE185263, GSE154918, GSE134347, and GSE100159. Divided the datasets into sepsis group and normal group, and use meta-analysis to evaluate the transcription level of S100A11 gene.The analysis shows that S100A11 is significantly overexpressed in the sepsis group (P < 0.01) Core gene (S100A11) survival curve Utilizing data from GSE65682, which includes 28-day prognostic information for over 400 sepsis patients.In this sepsis dataset, there were 239 cases in the S100A11 high expression group and 239 cases in the low expression group. As the observation time prolongs, the survival rate of sepsis patients decreases in both the S100A11 high expression group and the low expression group. In the early stage of sepsis, which is the inflammatory storm period, there is no significant difference in survival rate between the S100A11 high expression group and the low expression group. As the observation time extended, a significant difference in survival rate between the high expression group and the low expression group of S100A11 was observed (P < 0.05,Fig. 7). Based on GSE65682 dataset. Survival analysis revealed that the gene S100A11, which exhibited upregulated expression in sepsis, was significantly associated with sepsis outcomes qPCR validation of S100A11 gene transfection efficiency THP-1 cells were cultured and induced to differentiate into macrophages (Mø). The primers used for siRNA design were S100A11-F (5’-CGCCAAACGCACGAGTATT-3’) and S100A11-R (5’-ATGACAGAAAGGCTGGAAGGAA-3’), with a product size of 197 base pairs. Subsequently, the Lipo8000™ transfection reagent was added and the mixture was incubated at room temperature for 20 min. GAPDH served as the internal reference gene. Total RNA was extracted and isolated from each group using the RNAiso Plus reagent. RNA concentration was measured using a Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific, USA). Reverse transcription to synthesize cDNA was performed using TaKaRa’s PrimeScript™ RT reagent kit with gDNA Eraser (Perfect Real Time). Quantitative PCR (qPCR) was conducted using the PerfectStart® Green qPCR SuperMix kit in accordance with the manufacturer’s instructions, employing the qTOWER 3G Real-Time PCR System (Analytik Jena AG, Germany). The cycle threshold (Ct) values were determined, and relative expression levels were calculated using the 2^-ΔΔCt method. Figure 8 presents the experimental results, wherein NC denotes the reference gene and siRNA refers to the three introduced small interfering RNAs: siRNA1, siRNA2, and siRNA3. The findings demonstrate a significant reduction in the expression of S100A11 across all three groups (siRNA1, siRNA2, siRNA3) following the introduction of primers, indicating an effective siRNA interference effect (P < 0.05). These results warrant further experimental investigation. Presents the experimental results, wherein NC denotes the reference gene and siRNA corresponds to the three groups with the S100A11 primer incorporated, specifically siRNA1, siRNA2, and siRNA3. The findings demonstrate a significant reduction in the expression of S100A11 across all three groups (siRNA1, siRNA2, siRNA3) following the introduction of the primers, thereby indicating an effective siRNA interference effect (P < 0.05) ELISA detection of IL-1β, TNF-α, IL-6 Cultured THP-1 cells were divided into three groups: control, sepsis, and gene silence + sepsis. ELISA quantified the TNF-α, IL-β, and IL-6 levels in the cell supernatant.Multifactorial ANOVA was used to analyze the experimental data and compare the differences among the groups.Notable differences were found between the sepsis group and the control group, and also between the gene silence + sepsis group and the sepsis group (Fig. 9, P < 0.01). THP-1 cells were cultured to establish a sepsis model, which was categorized into three groups: control group, sepsis group, and sepsis group with S100A11 gene silencing, with each group comprising three samples. Each experiment was conducted in triplicate. The ELISA technique was employed to quantify inflammatory factors TNF-α, IL-β, and IL-6. Significant differences were observed in the levels of three inflammatory factors among the groups.The levels of inflammatory factors TNF - α, IL - β, and IL-6 in the sepsis group were significantly higher than those in the normal group (P < 0.01). The levels of inflammatory factors TNF - α, IL - β, and IL-6 in the S100A11 gene silencing group were significantly lower than those in the sepsis group (P < 0.01) Placement of hub genes in cellular clusters To elucidate the localization of core genes across various cell lines, peripheral blood samples were collected from two healthy volunteers, one patient with Systemic Inflammatory Response Syndrome (SIRS), and two patients with sepsis for 10× single-cell RNA sequencing. The raw high-throughput sequencing data were presented in FASTQ format. In collaboration with Oebiotech Biotechnology Co., Ltd., we completed the construction of a single-cell RNA library for sepsis, as well as RNA sequencing, data processing, and analysis. Sample quality statistics and alignment with the reference genome were conducted using the official 10× Genomics Cell Ranger software. Based on the preliminary quality control results from Cell Ranger, further quality control and data processing were performed using the Seurat package. Low-quality cells, including doublets, multiplets, and dead cells, were subsequently removed. Finally, principal component analysis (PCA) was employed for linear dimensionality reduction and quality control of gene expression data. The PCA results were visualized from a two-dimensional spatial perspective using the t-distributed stochastic neighbor embedding (t-SNE) nonlinear dimensionality reduction method. The genes that are significantly upregulated in each cell type are designated as marker genes. To identify these marker genes within each cell population, the FindAllMarkers function from the Seurat software package is employed. Subsequently, the identified marker genes are visualized using the VlnPlot and EigenPlot functions. For cell type annotation of sequencing data, the SingleR package is utilized, which is based on the Human Primary Cell Atlas (HPCA) reference dataset. This package facilitates correlation analysis between the reference dataset and the expression profiles of the cells under investigation. The results of the single-cell sequencing are stored on the Oebiotech single-cell transcriptome platform (https://cloud.oebiotech.cn/task/category/scrna/). We conducted a comparative analysis of gene expression in peripheral blood mononuclear cells (PBMCs) from healthy individuals and sepsis patients, identifying differentially expressed genes that were upregulated in the sepsis cohort, notably S100A11. The markers CD86 and CD206 are specific to M1 and M2 macrophages, respectively. Similar to CD86, S100A11 is predominantly expressed in macrophages (Fig. 10). In comparison to CD86, single-cell localization analysis indicates that S100A11 is predominantly expressed in macrophages Following the application of dimensionality reduction techniques to cluster the marker genes, the cells were categorized into nine distinct groups. Specifically, groups 3 and 5 correspond to macrophage populations, group 4 corresponds to natural killer cells, groups 1, 2, 6, and 8 correspond to T cell populations, group 7 corresponds to B cells, and group 9 corresponds to platelets (Fig. 11). The findings indicate that S100A11 expression is predominantly observed in macrophages. As shown in Fig. 11, groups 3 and 5 correspond to macrophage populations, group 4 corresponds to natural killer cells, groups 1, 2, 6, and 8 correspond to T cell populations, group 7 corresponds to B cells, and group 9 corresponds to platelets. The findings indicate that S100A11 expression is predominantly observed in macrophages Conclusions S100A11 is markedly overexpressed in patients with sepsis and serves as a critical gene that facilitates inflammation during the sepsis-associated inflammatory response. It is hypothesized that S100A11 plays a role in macrophage differentiation, immunomodulation, and the inflammatory responses associated with sepsis. Discussion Sepsis, a systemic inflammatory response syndrome initiated by infection, can advance to septic shock and multiple organ failure in severe instances, posing a serious threat to human health [33]. Consequently, early diagnosis and timely intervention in sepsis are of paramount importance [34]. Extensive research has demonstrated that inflammatory stress pervades the entire pathological progression of sepsis. Following the onset of sepsis, immune cells are activated, leading to the secretion of substantial quantities of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, to counteract the hyperactivation of immune cells. Therefore, mitigating the secretion of inflammatory cytokines is a crucial therapeutic target [35]. This research involved creating a septic cell model and using the ELISA technique to measure inflammatory cytokines TNF-α, IL-1β, and IL-6, which showed significant increases in sepsis. We aim to investigate whether there are biomarkers for early diagnosis in sepsis patients.In this study, 23 patients clinically diagnosed with sepsis and 10 individuals in a normal control group were included. Blood samples from both groups underwent gene sequencing, and the resulting data were analyzed using bioinformatics techniques.Differentially expressed genes (DEGs) in blood samples from sepsis patients and healthy adults were identified and analyzed. The 2,151 DEGs were analyzed for their functions using GO and KEGG. The results showed that these DEGs were mainly associated with biological processes like signal transduction, extracellular region, and extracellular space. Furthermore, they participated in signaling routes that include the differentiation of Th1, Th2, and Th17 cells.Staphylococcus aureus infection, and cytokine-cytokine receptor interaction. S100, part of the S100 protein family, plays a role in inflammatory responses [36]. S100A11, a specific member of this family, has the capacity to bind various proteins and activate signaling pathways that promote inflammatory responses. Liu et al. [37] demonstrated that the upregulation of S100A11 facilitates its binding to advanced glycation end products, thereby activating AMP-dependent protein kinase and STAT3 pathways for signal transduction, which in turn promote inflammatory responses in nasal mucosal epithelial cells. Similarly, Navrátilová et al. [37] found that S100A11 enhances the secretion of inflammatory cytokines by neutrophils, contributing to the progression of inflammatory responses in rheumatoid arthritis.We found that S100A11 is highly expressed in sepsis patients through peripheral blood gene sequencing and differential gene screening analysis. In this study, 23 patients clinically diagnosed with sepsis and 10 individuals in a normal control group were included. Blood samples from both groups underwent gene sequencing, and the resulting data were analyzed using bioinformatics techniques.Differentially expressed genes (DEGs) in blood samples from sepsis patients and healthy adults were identified and analyzed. The 2,151 DEGs were analyzed for their functions using GO and KEGG. The results showed that these DEGs were mainly associated with biological processes like signal transduction, extracellular region, and extracellular space. Furthermore, they participated in signaling routes that include the differentiation of Th1, Th2, and Th17 cells.Staphylococcus aureus infection, and cytokine-cytokine receptor interaction. Due to the limited number of sepsis samples collected in our clinical practice, we aim to analyze whether S100A11 is highly expressed in sepsis from multiple perspectives. We retrieved and screened 10 sets of sepsis datasets from the GEO public database: GSE163151, GSE232753, GSE95233, GSE69063, GSE243217, GSE236713, GSE185263, GSE154918, GSE134347, and GSE100159. These datasets were categorized into sepsis and control groups, and the transcription level of the gene S100A11 was examined through meta-analysis. The study found that S100A11 levels were much higher in the sepsis patients than in the normal adults. This finding corroborates the results obtained from gene sequencing, which also demonstrated elevated expression of S100A11 in the sepsis group. Consequently, we conclude that S100A11 is markedly upregulated in sepsis. We also want to know if the S100A11 gene is associated with the survival rate of sepsis patients. We filtered data from the GEO public database for GSE65682, which includes 28 day prognostic data for over 400 sepsis patients. Survival analysis of data from these sepsis patients revealed a difference in survival rates between the high and low expression groups of S100A11 gene. And it showed that the survival rate of sepsis patients with high expression of S100A11 was high, suggesting that S100A11 has a protective effect on sepsis. However, from the survival curve graph, it can be seen that there is no significant difference in survival rate between the S100A11 high expression group and the low expression group during the cytokine storm phase in the initial stage of sepsis. This result is consistent with the conclusion drawn from other results in this experiment that high expression of S100A11 promotes inflammatory response. Meanwhile, our single-cell localization analysis in the experiment also found that S100A11 is mainly expressed in macrophages. We speculate that as the patient’s condition progresses to the late stage of sepsis [38], namely the inflammation resolution phase or immune suppression phase, high expression of S100A11 may balance the immune system and prevent sepsis patients from dying from immune paralysis [39], thereby exhibiting a high survival rate. Liang et al. [40] demonstrated that S100A11 can interact with STAT6 to enhance its expression and activate macrophages, thereby promoting the onset and progression of lung inflammation in asthmatic mice. Our single-cell localization analysis of the S100A11 gene indicated that its expression is predominantly localized in macrophages.We performed KEGG functional enrichment analysis on the identified differentially expressed genes between the septic and normal groups. Our examination uncovered that these genes are implicated in biological processes such as Th1, Th2, and Th17 cells undergo differentiation. From these results, we propose that S100A11 could be involved in macrophage differentiation, immune regulation, and the inflammatory response linked to sepsis. In our experiment, we established a sepsis cell model by stimulating THP-1 derived macrophages with LPS. The sepsis model established by LPS stimulated cells is a common but highly simplified in vitro model of sepsis. However, sepsis is a complex systemic disease involving multiple cell types, progressing from highly inflammatory (SIRS) to immunosuppressive (CARS) stages. Further research is needed to investigate the role of S100A11 in sepsis animal models or in vivo. The relationship between the expression of S100A11 and macrophage differentiation, immune regulation, and inflammatory response is still unclear. The specific mechanism of enhanced expression of S100A11 in sepsis also needs further investigation. We will establish an animal model of sepsis in the future to further investigate the high expression and mechanism of S100A11, as well as the mechanism affecting the inflammatory response in sepsis. Limitations Our experiment was based on bioinformatics analysis of RNA sequencing results from 23 sepsis patients and 10 healthy volunteers. There is a limitation of small sample size. Therefore, we also used meta-analysis to support the discovery of high expression of S100A11. Hope to provide some research basis for screening biomarkers of sepsis. LPS stimulation of THP-1 derived macrophages is a common but highly simplified in vitro model of sepsis. Sepsis is a complex systemic disease involving multiple cell types, progressing from highly inflammatory (SIRS) to immunosuppressive (CARS) stages. Further research is needed to investigate the situation of S100A11 in sepsis animal models or in vivo. Our research discovered that S100A11 is significantly expressed in sepsis. Furthermore, our results suggest that S100A11 is a key gene that facilitates inflammation during the septic inflammatory response and may be involved in macrophage differentiation, immunomodulation, and inflammatory processes. Further research is needed to clarify how S100A11 impacts the inflammatory response during sepsis. Acknowledgements Not applicable. Authors’ contributions Hongying Cao is the first author. Wei Wang is the corresponding author.Wei Wang guided the entire experimental process. Hongying Cao and Wei Wang designed the experiment. Hongying Cao, Nianying Qin, Yiling Zhai, and Chunyang Dong conducted experiments and applied for clinical ethics approval. Jincheng Li and Jie Yang collected and analyzed data. Zhou Huang, Dongling Huang, Fan Wang, and Wanxia Wei obtained clinical samples. Hongying Cao wrote and revised the manuscript.Hongying Cao and Wei Wang can confirm the authenticity of all original data. All authors have read and approved the final version of the manuscript. Funding The present study was supported by Research Project of Southwest Medical University (grant no. 0903-00031431).The Training Project of “139” Program for High-Level Medical Talents in Guangxi (No. G201903034).The Research and Demonstration Application of Snakebite Bigdata Platform Based on Virtual Standardized Snakebite Treatment Model (No. 22QYCX0046). Data availability We intend to share individual deidentified participant data. Peripheral blood RNA sequencing data from 23 patients with sepsis and 10 normal controls are available in the China National GeneBank DataBase (CNGBdb) and can be found below: https://db.cngb.org/, under the accession: CNP0002611, it’s valid forever. Declarations Ethics approval and consent to participate This research project received approval from the Ethics Committee of the Affiliated Hospital of Southwest Medical University, with the ethics approval number ky2018029. All individuals, gave their informed consent in writing. Consent for publication The authors agree to publish. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement We intend to share individual deidentified participant data. Peripheral blood RNA sequencing data from 23 patients with sepsis and 10 normal controls are available in the China National GeneBank DataBase (CNGBdb) and can be found below: https://db.cngb.org/, under the accession: CNP0002611, it’s valid forever.